1P-S2-4
Michael Tynan MD, FRCP
Emeritus
Professor of Paediatric Cardiology, Kings College, London, UK
Since the late 1940s surgical
correction has been the recognised treatment for aortic coarctation. Results,
in terms of long-term survival have been excellent in older children and
adolescents. Problems have been concentrated in those operated on in infancy
and adult life. From the mid 1980’s balloon dilation has been employed,
initially for the treatment of re-coarctation or persistent coarctation
following surgical repair and then as primary treatment of ‘native’
coarctation. Reservations about employing balloon dilation as primary treatment
centre on the: risk of aneurysm and a high incidence of restenosis in young
infants. Furthermore the balloon dilation of coarctation after surgical
treatment is effective in only 75. The risk of aneurysm in children for both
‘native’ coarctation and for recoarctation is in the region of 2-5% and is
considered acceptable by many workers, patients and parents. Adverse aortic
arch anatomy means that dilation is not generally recommended in neonates. In
older patients with recoarctation and ‘native’ coarctation stent implantation
has recently proved successful in relieving stenosis.